Insulin Degludec vs Secretin
Head-to-head comparison of Insulin Degludec (Insulin degludec (desB30, acylated ultra-long-acting insulin analog)) and Secretin (Human Secretin) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Insulin Degludec | Secretin |
|---|---|---|
| Category | Diabetes & Metabolic | Gastrointestinal |
| Full Name | Insulin degludec (desB30, acylated ultra-long-acting insulin analog) | Human Secretin |
| Molecular Weight | 6103.9 Da | 3055.4 Da |
| Half-Life | More than 25 hours | 5-7 minutes |
| Amino Acids | 50 | 27 |
| Typical Dose | 0.1-0.2 U/kg once daily | 0.2 mcg/kg IV |
| Route | Subcutaneous | Intravenous |
| Purity | ≥98% | ≥98% |
| Studies Count | 7000 | 800 |
| Research Status | Approved | Clinical |
Insulin Degludec Benefits
- ✓Ultra-long basal coverage
- ✓Lower day-to-day variability
- ✓Reduced nocturnal hypoglycemia
- ✓Flexible dosing time
Secretin Benefits
- ✓stimulates-pancreatic-secretion
- ✓supports-bicarbonate-release
- ✓aids-duodenal-pH-control
- ✓helps-digestive-coordination
Insulin Degludec Dosing
Inject SC once daily|Titrate to fasting glucose and HbA1c response|May be administered with flexible timing in adults
Secretin Dosing
0.2 mcg/kg IV diagnostic dose|research infusion protocols|short bolus administration
Insulin Degludec Side Effects
- ⚠Hypoglycemia
- ⚠Injection-site reactions
- ⚠Weight gain
Secretin Side Effects
- ⚠flushing
- ⚠nausea
- ⚠abdominal-cramping
Research Overview
Insulin Degludec
Studies highlight prolonged action and lower glycemic variability compared with many other basal insulins. It is frequently used in research on ultra-long basal coverage and hypoglycemia reduction.
Secretin
Secretin is a classic GI hormone with extensive physiology literature and established diagnostic use. It remains important for studying pancreatic secretory function, biliary responses, and duodenal feedback.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.